Andres helps clients with a variety of matters in the constantly evolving health care industry to serve health care providers’ business and legal objectives. He provides comprehensive representation and strategic counsel to a variety of health care providers, including hospitals and health systems, physician groups, individual health care professionals, home health agencies and long-term care providers.

Education

  • Sandra Day O’Connor College of Law at Arizona State University (J.D., 2024)
    • Chicano Latino Law Students Association, Professional Development Chair, Pro-bono Chair
    • Jurimetrics: The Journal of Law, Science, and Technology, Executive Editor
  • University of Missouri-Columbia (B.A., 2021)
    • Philosophy & Economics
    • Phi Beta Kappa Honor Society, Member

Bar Admission

  • Arizona

Recognition

  • CALI Award for Excellence in Business Organizations
  • William H. Pedrick Scholar, Spring 2022; Fall 2022

Languages

  • Spanish
Publications
2025 Health Care Reimbursement Newsletter
Polsinelli is pleased to share the Health Care Reimbursement Newsletter. This publication contains articles and insight into issues that affect Reimbursement. In this issue: Steps Congress May Take To Fix Reimbursement in 2025 Six Updates to Provider Enrollment in 2024 You Need to Know Utilization Management Changes to Medicare Advantage New Year, New 340B Program? Manufacturers Seek to Change the 340B Program Landscape Reimbursement Perspectives from the Host of The 10 Minute HealthBizCast The Latest in Government Audits: Three Lessons for Providers Medicaid in 2025: What Stays, What Changes and How to Prepare Continued Focus on the No Surprises Act and Hospital Price Transparency What You Need to Know About Home Health & Hospice Reimbursement in 2025 CMS Updates its Interpretation of the 60-Day Overpayment Rule IPPS Highlights Medicare Physician Fee Schedule Skilled Nursing Facility
Read More
Swing and a Miss: the Government Strikes Out in Pharmacy Executive Kickback Trial
Last week, the government submitted its decision to the federal court not to retry partially-acquitted pharmacy executive, Chad Beene, for conspiracy and illegal kickback allegations. At the end of last year, a New Jersey jury partially acquitted Mr. Beene on charges related to an alleged $34 million illegal kickback scheme. At trial, federal prosecutors alleged that Mr. Beene and his colleagues crafted an illegal scheme through which they paid several marketing companies illegal kickbacks for securing prescriptions of “medically unnecessary” and “exorbitantly priced” compounded medications. While three of the indicted alleged co-conspirators pleaded guilty, Mr. Beene took the case to trial and was found not guilty on six counts. The jury was unable to reach a verdict on nine additional
Read More